Skip to main content
. Author manuscript; available in PMC: 2012 Oct 24.
Published in final edited form as: Synapse. 2012 Feb 28;66(6):471–482. doi: 10.1002/syn.21515

TABLE I.

Characteristics of participants who received single-photon emission-computed tomography (SPECT) of the brain for sixty (60) minutes, twenty-four (24) hours following the intravenous injection of approximately 333 MBq (9 mCi) (−)-5-[123I]iodobenzovesamicol ([123I]IBVM)

Diagnosis Age in years Sex Ethnicity Arterial blood sampling [123I]IBVM in MBq (mCi) VATSBI
Healthy 19 M C 1 approximately 333 (9.00) 8.14
Healthy 21 M C 1 344.1 (9.30) 5.88
Healthy 27 F A 1 268.99 (7.27) 6.47
Healthy 28 M A 1 334.11 (9.03) 3.66
Healthy 31 F AA 0 280.83 (7.59) 5.30
Healthy 32 F AA 0 333 (9.00) 3.34
Healthy 33 F AA 0 approximately 333 (9.00) 5.88
Healthy 34 F C 1 approximately 333 (9.00) 6.96
Healthy 44 F AA 1 340.4 (9.20) missinga
Rett syndrome 19 F AA 0 321.9 (8.70) 4.26
Rett syndrome 21 F C 0 approximately 333 (9.00) 6.34
Rett syndrome 22 F C 0 approximately 333 (9.00) 4.82
Rett syndrome 31 F C 0 257.15 (6.95) 5.34

0 = no, 1 = yes; A = Asian; AA = African-American; C = Caucasian; F = female; M = male; VATSBI = Vesicular Acetylcholine Transporter Binding Site Index.

a

Meaningful data was not obtained due to technical malfunction of the gamma counter.